 | • レポートコード：MRC23Q36094 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のIn Vitro無細胞タンパク質発現市場について調査・分析し、世界のIn Vitro無細胞タンパク質発現市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（大腸菌無細胞タンパク質発現系、小麦胚芽無細胞タンパク質発現系、昆虫細胞無細胞タンパク質発現系、哺乳類無細胞タンパク質発現系、その他）、用途別セグメント分析（製薬会社、研究機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Promega、Takara Bio、New England Biolabs、Creative Biolabs、CellFree Sciences、Synthelis、Arbor Bioscience、Cube Biotech、Cambridge Isotope Laboratories、Profacgen、Bioneer、GeneCopoeiaなどが含まれています。世界のIn Vitro無細胞タンパク質発現市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、In Vitro無細胞タンパク質発現市場規模を推定する際に考慮しました。本レポートは、In Vitro無細胞タンパク質発現の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、In Vitro無細胞タンパク質発現に関するビジネス上の意思決定に役立てることを目的としています。 ・In Vitro無細胞タンパク質発現市場の概要 - In Vitro無細胞タンパク質発現のタイプ別セグメント - 世界のIn Vitro無細胞タンパク質発現市場規模：タイプ別分析（大腸菌無細胞タンパク質発現系、小麦胚芽無細胞タンパク質発現系、昆虫細胞無細胞タンパク質発現系、哺乳類無細胞タンパク質発現系、その他） - In Vitro無細胞タンパク質発現の用途別セグメント - 世界のIn Vitro無細胞タンパク質発現市場規模：用途別分析（製薬会社、研究機関、その他） - 世界のIn Vitro無細胞タンパク質発現市場規模予測（2018年-2029年） ・In Vitro無細胞タンパク質発現市場の成長トレンド - In Vitro無細胞タンパク質発現の地域別市場規模（2018年-2029年） - In Vitro無細胞タンパク質発現市場ダイナミクス - In Vitro無細胞タンパク質発現の業界動向 - In Vitro無細胞タンパク質発現市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：大腸菌無細胞タンパク質発現系、小麦胚芽無細胞タンパク質発現系、昆虫細胞無細胞タンパク質発現系、哺乳類無細胞タンパク質発現系、その他 - 世界のIn Vitro無細胞タンパク質発現のタイプ別市場規模（2018年-2023年） - 世界のIn Vitro無細胞タンパク質発現のタイプ別市場規模（2024年-2029年） ・用途別セグメント：製薬会社、研究機関、その他 - 世界のIn Vitro無細胞タンパク質発現の用途別市場規模（2018年-2023年） - 世界のIn Vitro無細胞タンパク質発現の用途別市場規模（2024年-2029年） ・In Vitro無細胞タンパク質発現の地域別市場規模 - 北米のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - アメリカのIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - ヨーロッパのIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - アジア太平洋のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - 中国のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - 日本のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - 韓国のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - インドのIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - オーストラリアのIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - 中南米のIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） - 中東・アフリカのIn Vitro無細胞タンパク質発現市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Thermo Fisher Scientific、Promega、Takara Bio、New England Biolabs、Creative Biolabs、CellFree Sciences、Synthelis、Arbor Bioscience、Cube Biotech、Cambridge Isotope Laboratories、Profacgen、Bioneer、GeneCopoeia ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global In Vitro Cell-free Protein Expression market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for In Vitro Cell-free Protein Expression is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for In Vitro Cell-free Protein Expression is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for In Vitro Cell-free Protein Expression in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of In Vitro Cell-free Protein Expression include Thermo Fisher Scientific, Promega, Takara Bio, New England Biolabs, Creative Biolabs, CellFree Sciences, Synthelis, Arbor Bioscience and Cube Biotech, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Cell-free Protein Expression, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Cell-free Protein Expression.
The In Vitro Cell-free Protein Expression market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Cell-free Protein Expression market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Cell-free Protein Expression companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Promega
Takara Bio
New England Biolabs
Creative Biolabs
CellFree Sciences
Synthelis
Arbor Bioscience
Cube Biotech
Cambridge Isotope Laboratories
Profacgen
Bioneer
GeneCopoeia
Segment by Type
E.Coli Cell-Free Protein Expression System
Wheat Germ Cell-Free Protein Expression System
Insect Cells Cell-Free Protein Expression System
Mammalian Cell-Free Protein Expression System
Others
Segment by Application
Pharmaceutical Companies
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Cell-free Protein Expression companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Cell-free Protein Expression Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 E.Coli Cell-Free Protein Expression System
1.2.3 Wheat Germ Cell-Free Protein Expression System
1.2.4 Insect Cells Cell-Free Protein Expression System
1.2.5 Mammalian Cell-Free Protein Expression System
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Cell-free Protein Expression Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Cell-free Protein Expression Market Perspective (2018-2029)
2.2 In Vitro Cell-free Protein Expression Growth Trends by Region
2.2.1 Global In Vitro Cell-free Protein Expression Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Cell-free Protein Expression Historic Market Size by Region (2018-2023)
2.2.3 In Vitro Cell-free Protein Expression Forecasted Market Size by Region (2024-2029)
2.3 In Vitro Cell-free Protein Expression Market Dynamics
2.3.1 In Vitro Cell-free Protein Expression Industry Trends
2.3.2 In Vitro Cell-free Protein Expression Market Drivers
2.3.3 In Vitro Cell-free Protein Expression Market Challenges
2.3.4 In Vitro Cell-free Protein Expression Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Cell-free Protein Expression Players by Revenue
3.1.1 Global Top In Vitro Cell-free Protein Expression Players by Revenue (2018-2023)
3.1.2 Global In Vitro Cell-free Protein Expression Revenue Market Share by Players (2018-2023)
3.2 Global In Vitro Cell-free Protein Expression Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Cell-free Protein Expression Revenue
3.4 Global In Vitro Cell-free Protein Expression Market Concentration Ratio
3.4.1 Global In Vitro Cell-free Protein Expression Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Cell-free Protein Expression Revenue in 2022
3.5 In Vitro Cell-free Protein Expression Key Players Head office and Area Served
3.6 Key Players In Vitro Cell-free Protein Expression Product Solution and Service
3.7 Date of Enter into In Vitro Cell-free Protein Expression Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Cell-free Protein Expression Breakdown Data by Type
4.1 Global In Vitro Cell-free Protein Expression Historic Market Size by Type (2018-2023)
4.2 Global In Vitro Cell-free Protein Expression Forecasted Market Size by Type (2024-2029)
5 In Vitro Cell-free Protein Expression Breakdown Data by Application
5.1 Global In Vitro Cell-free Protein Expression Historic Market Size by Application (2018-2023)
5.2 Global In Vitro Cell-free Protein Expression Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In Vitro Cell-free Protein Expression Market Size (2018-2029)
6.2 North America In Vitro Cell-free Protein Expression Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Cell-free Protein Expression Market Size by Country (2018-2023)
6.4 North America In Vitro Cell-free Protein Expression Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Cell-free Protein Expression Market Size (2018-2029)
7.2 Europe In Vitro Cell-free Protein Expression Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Cell-free Protein Expression Market Size by Country (2018-2023)
7.4 Europe In Vitro Cell-free Protein Expression Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Cell-free Protein Expression Market Size (2018-2029)
8.2 Asia-Pacific In Vitro Cell-free Protein Expression Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Cell-free Protein Expression Market Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Cell-free Protein Expression Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Cell-free Protein Expression Market Size (2018-2029)
9.2 Latin America In Vitro Cell-free Protein Expression Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Cell-free Protein Expression Market Size by Country (2018-2023)
9.4 Latin America In Vitro Cell-free Protein Expression Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Cell-free Protein Expression Market Size (2018-2029)
10.2 Middle East & Africa In Vitro Cell-free Protein Expression Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Cell-free Protein Expression Market Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Cell-free Protein Expression Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vitro Cell-free Protein Expression Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Promega
11.2.1 Promega Company Detail
11.2.2 Promega Business Overview
11.2.3 Promega In Vitro Cell-free Protein Expression Introduction
11.2.4 Promega Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.2.5 Promega Recent Development
11.3 Takara Bio
11.3.1 Takara Bio Company Detail
11.3.2 Takara Bio Business Overview
11.3.3 Takara Bio In Vitro Cell-free Protein Expression Introduction
11.3.4 Takara Bio Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.3.5 Takara Bio Recent Development
11.4 New England Biolabs
11.4.1 New England Biolabs Company Detail
11.4.2 New England Biolabs Business Overview
11.4.3 New England Biolabs In Vitro Cell-free Protein Expression Introduction
11.4.4 New England Biolabs Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.4.5 New England Biolabs Recent Development
11.5 Creative Biolabs
11.5.1 Creative Biolabs Company Detail
11.5.2 Creative Biolabs Business Overview
11.5.3 Creative Biolabs In Vitro Cell-free Protein Expression Introduction
11.5.4 Creative Biolabs Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.5.5 Creative Biolabs Recent Development
11.6 CellFree Sciences
11.6.1 CellFree Sciences Company Detail
11.6.2 CellFree Sciences Business Overview
11.6.3 CellFree Sciences In Vitro Cell-free Protein Expression Introduction
11.6.4 CellFree Sciences Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.6.5 CellFree Sciences Recent Development
11.7 Synthelis
11.7.1 Synthelis Company Detail
11.7.2 Synthelis Business Overview
11.7.3 Synthelis In Vitro Cell-free Protein Expression Introduction
11.7.4 Synthelis Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.7.5 Synthelis Recent Development
11.8 Arbor Bioscience
11.8.1 Arbor Bioscience Company Detail
11.8.2 Arbor Bioscience Business Overview
11.8.3 Arbor Bioscience In Vitro Cell-free Protein Expression Introduction
11.8.4 Arbor Bioscience Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.8.5 Arbor Bioscience Recent Development
11.9 Cube Biotech
11.9.1 Cube Biotech Company Detail
11.9.2 Cube Biotech Business Overview
11.9.3 Cube Biotech In Vitro Cell-free Protein Expression Introduction
11.9.4 Cube Biotech Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.9.5 Cube Biotech Recent Development
11.10 Cambridge Isotope Laboratories
11.10.1 Cambridge Isotope Laboratories Company Detail
11.10.2 Cambridge Isotope Laboratories Business Overview
11.10.3 Cambridge Isotope Laboratories In Vitro Cell-free Protein Expression Introduction
11.10.4 Cambridge Isotope Laboratories Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.10.5 Cambridge Isotope Laboratories Recent Development
11.11 Profacgen
11.11.1 Profacgen Company Detail
11.11.2 Profacgen Business Overview
11.11.3 Profacgen In Vitro Cell-free Protein Expression Introduction
11.11.4 Profacgen Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.11.5 Profacgen Recent Development
11.12 Bioneer
11.12.1 Bioneer Company Detail
11.12.2 Bioneer Business Overview
11.12.3 Bioneer In Vitro Cell-free Protein Expression Introduction
11.12.4 Bioneer Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.12.5 Bioneer Recent Development
11.13 GeneCopoeia
11.13.1 GeneCopoeia Company Detail
11.13.2 GeneCopoeia Business Overview
11.13.3 GeneCopoeia In Vitro Cell-free Protein Expression Introduction
11.13.4 GeneCopoeia Revenue in In Vitro Cell-free Protein Expression Business (2018-2023)
11.13.5 GeneCopoeia Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details